571
Views
13
CrossRef citations to date
0
Altmetric
Clinical Study

Impact of Volume Status on Blood Pressure and Left Ventricle Structure in Patients Undergoing Chronic Hemodialysis

, , , , , , & show all
Pages 377-381 | Received 05 Oct 2010, Accepted 16 Feb 2011, Published online: 30 Apr 2011

References

  • Hull A, Long D, Pettinger WA, Parker TF, III. The control of hypertension in patients undergoing regular maintenance hemodialysis. Kidney Int. 1974;7(Suppl. 2):187–194.
  • Goodkin DA, Bragg-Gresham JL, Koenig KG, Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270–3277.
  • Salem MM. Hypertension in the hemodialysis population: A survey of 649 patients. Am J Kidney Dis. 1995;26:461–468.
  • Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW. Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects. Am J Kidney Dis. 2004;44:16–21.
  • Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM. Sodium balance in renal failure: A comparison of patients with normal subjects under extremes of sodium intake. Hypertension. 1985;7:714–721.
  • Kooman JP, Van Der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients: Reflections on pathophysiological mechanisms. Blood Purif. 2004;22:55–59.
  • Zoccali C, Benedetto FA, Tripepi G, Mallamaci F. Cardiac consequences of hypertension in hemodialysis patients. Semin Dial. 2004;17:299–303.
  • Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol. 1994;4:1486–1490.
  • Cuspidi C, Ciulla M, Zanchetti A. Hypertensive myocardial fibrosis. Nephrol Dial Transplant. 2006;21:20–23.
  • Stewart GA, Gansevoort RT, Mark PB, Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2005;67:217–226.
  • Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12:1079–1084.
  • K/DOQI. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(Suppl. 3):16–153.
  • Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–618.
  • Devereux RB, Lutas EM, Casale PN, Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222–1230.
  • Foley RN, Parfrey PS, Harnett JD, Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–192.
  • Tucker B, Fabbian F, Giles M, Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant. 1997;12:724–728.
  • Erturk S, Ertug AE, Ates K, Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in hemodialysis patients. Nephrol Dial Transplant. 1996;11:2050–2054.
  • Foley R, Herzog C, Collins A. Blood pressure and long-term mortality in United States hemodialysis patients: ESRD waves 3 and 4 study. Kidney Int. 2002;62:1784–1790.
  • Mendes R, Santos S, Dorigo D, The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in hemodialysis patients. Blood Pres Monit. 2003;8:243–248.
  • Verdecchia P, Porcellati C, Schillaci G, Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801.
  • Dolan E, Stanton A, Thijs L, Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 2005;46:156–161.
  • Clement DL, De Buyzere ML, De Bacquer DA, Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–2415.
  • Peixoto A, Santos S, Mendes R, Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis. 2000;36:983–990.
  • Nystrom F, Malmqvist K, Ohman KP, Kahan T. Nurse recorded and ambulatory blood pressure predicts treatment induced reduction of left ventricular hypertrophy equally well in hypertension: Results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study. J Hypertens. 2002;20:1527–1533.
  • Zoccali C, Mallamaci F, Tripepi G, Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens. 1999;17:1751–1758.
  • Cannella G, Paoletti E, Ravera G, Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int. 2000;58:260–268.
  • Amar J, Vernier I, Rossignol E, Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–2491.
  • Tripepi G, Fagugli RM, Dattolo P, Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int. 2005;68:1294–1302.
  • Agarwal R. Assessment of blood pressure in hemodialysis patients. Semin Dial. 2002;15(5):299–304.
  • Leypoldt J, Cheung A, Delmez J, Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002;61:266–275.
  • Khosla U, Johnson R. Hypertension in the hemodialysis patient and the “lag phenomenon”: Insights into pathophysiology and clinical management. Am J Kidney Dis. 2004;43:739–751.
  • Blankestijn P. Sympathetic hyperactivity in chronic kidney disease. Nephrol Dial Transplant. 2004;19:1354–1357.
  • Luik AJ, Gladziwa U, Kooman JP, Influence of interdialytic weight gain on blood pressure in hemodialysis patients. Blood Purif. 1994;12:259–266.
  • Luik AJ, van Kuijk WHM, Spek J, Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis. 1997;30:466–474.
  • Rahman M, Dixit A, Donley V, Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis. 1999;33:498–506.
  • Rocco MV, Yan G, Heyka RJ, Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO Study. Am J Nephrol. 2001;21:280–288.
  • Inrig JK, Patel UD, Gillespie BS, Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis. 2007;50(1):108–118.
  • Mominadam S, Ozkahya M, Kayikcioglu M, Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients. Hemodial Int. 2008;12:322–327.
  • Kayikcioglu M, Tumuklu M, Ozkahya M, The benefit of salt restriction in the treatment of end-stage renal disease by hemodialysis. Nephrol Dial Transplant. 2009;24(3):956–962.
  • Gunal AI, Kirciman E, Guler M, Yavuzkir M, Celiker H. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients? Ren Fail. 2004;26(4): 405–409.
  • Gunal AI, Karaca I, Aygen B, Yavuzkir M, Dogukan A, Celiker H. Strict fluid volume control and left ventricular hypertrophy in hypertensive patients on chronic hemodialysis: A cross-sectional study. J Int Med Res. 2004;32(1):70–77.
  • Covic A, Goldsmith DJ, Covic M Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients. Am J Kidney Dis. 2000;35:617–623.
  • Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit. 2009;14:2–11.
  • Verdecchia P, Schillaci G, Guerrieri M, Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–536.
  • Verdecchia P, Angeli F, Cavallini C. Ambulatory blood pressure for cardiovascular risk stratification. Circulation. 2007;115:2091–2093.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.